Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells

Oncology Letters

Volumn 6, Issue 1, 2013, Pages 232-238

  Xie, Jin ^a   Li, Da Wei ^b   Chen, Xin Wei ^a   Wang, Fei ^a   Dong, Pin ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Hypoxia; Hypoxia inducible factor 1 ; Laryngeal neoplasms; Multidrug resistance; P glycoprotein

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; HYPOXIA INDUCIBLE FACTOR 1ALPHA GENE; IMMUNOHISTOCHEMISTRY; LARYNX SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE PROTEIN 1 GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84878278103     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1321     Document Type: Article

References (31)

1. Wilson WR and Hay MP: Targeting hypoxia in cancer therapy. Nat Rev Cancer 11: 393-410, 2011.
2. Li Y and Ye D: Cancer-therapy by targeting hypoxia-inducible factor-1. Curr Cancer Drug Targets 10: 782-796, 2010.
3. O'Donnell JL, Joyce MR, Shannon AM, Harmey J, Geraghty J and Bouchier-Hayes D: Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression. Cancer Treat Rev 32: 407-416, 2006.
4. Liu LZ, Li C, Chen Q, et al: MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression. PLoS One 6: e19139, 2011.
5. Park SY, Jang WJ, Yi EY, Jang JY, Jung Y, Jeong JW and Kim YJ: Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res 48: 178-184, 2010.
6. Jing SW, Wang YD, Kuroda M, et al: HIF-1α contributes to hypoxia-induced invasion and metastasis of esophageal carcinoma via inhibiting E-cadherin and promoting MMP-2 expression. Acta Med Okayama 66: 399-407, 2012.
7. Song G, Ouyang G, Mao Y, Ming Y, Bao S and Hu T: Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha upregulation and MMP9 activation. J Cell Mol Med 13: 1706-1718, 2009.
8. Huang L, Zhang Z, Zhang S, et al: Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathway. Int J Mol Med 27: 407-415, 2011.
9. Rho JK, Choi YJ, Lee JK, et al: Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha. Oncol Rep 21: 801-807, 2009.
10. Huang C, Xu D, Xia Q, Wang P, Rong C and Su Y: Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II. J Pharm Pharmacol 64: 1741-1750, 2012.
11. Wu XH, Lu YF, Hu XD, Mao JY, Ji XX, Yao HT and Zhou SH: Expression of hypoxia inducible factor-1α and its significance in laryngeal carcinoma. J Int Med Res 38: 2040-2046, 2010.
12. Cabanillas R, Rodrigo JP, Secades P, Astudillo A, Nieto CS and Chiara MD: The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer. J Surg Oncol 99: 373-378, 2009.
13. Hao YX, He ZW, Zhu JH, Shen Q, Sun JZ, Du N and Xiao WH: Reversal of multidrug resistance in renal cell carcinoma by short hairpin RNA targeting MDR1 gene. Chin Med J (Engl) 125: 2741-2745, 2012.
14. Li L, Jiang AC, Dong P, Wan Y and Yu ZW: The characteristics of Hep-2 cell with multiple drug resistance induced by Taxol. Otolaryngol Head Neck Surg 137: 659-664, 2007.
15. Zhigang H, Qi Z, Jugao F, et al: Reverse multidrug resistance in laryngeal cancer cells by knockdown MDR1 gene expression. J Otolaryngol Head Neck Surg 38: 440-448, 2009.
16. Ding Z, Yang L, Xie X, et al: Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells. J Cancer Res Clin Oncol 136: 1697-1707, 2010.
17. Zhu H, Luo SF, Wang J, et al: Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1α. Chin Med J (Engl) 125: 1095-1103, 2012.
18. Psychogios G, Waldfahrer F, Bozzato A and Iro H: Evaluation of the revised TNM classification in advanced laryngeal cancer. Eur Arch Otorhinolaryngol 267: 117-121, 2010.
19. Batmunkh E, Shimada M, Morine Y, et al: Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma. Int J Clin Oncol 15: 59-64, 2010.
20. Ng IO, Liu CL, Fan ST and Ng M: Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol 113: 355-363, 2000.
21. Sowter HM, Raval RR, Moore JW, Ratcliffe PJ and Harris AL: Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res 63: 6130-6134, 2003.
22. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] Method. Methods 25: 402-408, 2001.
23. Li L, Jiang AC, Dong P, Wang H, Xu W and Xu C: MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol. Ann Surg Oncol 16: 1421-1428, 2009.
24. Miletti-González KE, Chen S, Muthukumaran N, et al: The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res 65: 6660-6667, 2005.
25. Tokunaga Y, Hosogi H, Hoppou T, Nakagami M, Tokuka A and Ohsumi K: Effects of MDR1/P-glycoprotein expression on prognosis in advanced colorectal cancer after surgery. Oncol Rep 8: 815-819, 2001.
26. Sagol O, Yavuzsen T, Oztop I, et al: The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma. Pancreas 30: 343-348, 2005.
27. Wartenberg M, Ling FC, Müschen M, et al: Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J 17: 503-505, 2003.
28. Xia S, Yu SY, Yuan XL and Xu SP: Effects of hypoxia on expression of P-glycoprotein and multidrug resistance protein in human lung adenocarcinoma A549 cell line. Zhonghua Yi Xue Za Zhi 84: 663-666, 2004 (In Chinese).
29. Song X, Liu X, Chi W, Liu Y, Wei L, Wang X and Yu J: Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol 58: 776-784, 2006.
30. Liu L, Ning X, Sun L, et al: Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99: 121-128, 2008.
31. Min L, Chen Q, He S, Liu S and Ma Y: Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression. Mol Med Report 5: 228-232, 2012.